Skip to main
RDNT
RDNT logo

RadNet (RDNT) Stock Forecast & Price Target

RadNet (RDNT) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

RadNet Inc. has a positive outlook due to its ongoing investments in technology that are expected to enhance productivity and automation while navigating a challenging labor environment. The company's joint venture (JV) strategy is expected to boost volume growth, market penetration, and contracting leverage over time, further strengthening its competitive position. Additionally, strong demand trends and persistent patient backlogs, particularly in advanced procedure categories, have contributed to significant growth, with these categories representing 27.5% of volumes in the second quarter and a notable year-over-year margin improvement.

Bears say

RadNet Inc faces significant risks that contribute to a negative outlook, including potential pressures and changes related to reimbursement, which could adversely impact revenue streams. Additionally, the company is grappling with labor challenges that may hinder operational efficiency and profitability, particularly within its Digital Health segment that focuses on AI applications. While the rollout of the TechLive system has shown initial promise in reducing MRI room closures, the ongoing issues suggest a challenging path ahead for sustainable growth and financial stability.

RadNet (RDNT) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RadNet and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RadNet (RDNT) Forecast

Analysts have given RadNet (RDNT) a Strong Buy based on their latest research and market trends.

According to 5 analysts, RadNet (RDNT) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RadNet (RDNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.